Literature DB >> 18775672

New insights into NF-kappaB regulation and function.

Shao-Cong Sun1, Steven C Ley.   

Abstract

NF-kappaB (nuclear factor-kappaB) transcription factors have multiple critical roles in the regulation of immune responses. In unstimulated cells, NF-kappaB proteins are sequestered in the cytoplasm by IkappaB inhibitory proteins. Various immune stimuli induce the IkappaB kinase (IKK) to phosphorylate IkappaBs, triggering their ubiquitination and proteasomal degradation, which permits nuclear translocation of associated NF-kappaB subunits and activation of NF-kappaB target genes. Recent studies have highlighted the importance of dynamic ubiquitination-deubiquitination events in regulating this canonical NF-kappaB signaling pathway. Ubiquitination additionally plays critical roles in activation of the noncanonical pathway that regulates NF-kappaB via signal-induced processing of NF-kappaB2 p100. New research has also identified several novel regulatory proteins that control the transcriptional activity of nuclear NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775672      PMCID: PMC5751948          DOI: 10.1016/j.it.2008.07.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  76 in total

1.  Epigenetic control: slow and global, nimble and local.

Authors:  Christine S Cheng; Tracy L Johnson; Alexander Hoffmann
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

2.  The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.

Authors:  Lakshmanan Ganesh; Ezra Burstein; Anuradha Guha-Niyogi; Mark K Louder; John R Mascola; Leo W J Klomp; Cisca Wijmenga; Colin S Duckett; Gary J Nabel
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

3.  Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.

Authors:  Ato Wright; William W Reiley; Mikyoung Chang; Wei Jin; Andrew Joon Lee; Minying Zhang; Shao-Cong Sun
Journal:  Dev Cell       Date:  2007-11       Impact factor: 12.270

4.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

5.  Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation.

Authors:  Dietrich B Conze; Chuan-Jin Wu; James A Thomas; Allison Landstrom; Jonathan D Ashwell
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

6.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.

Authors:  Guozhi Zhu; Chuan-Jin Wu; Yongge Zhao; Jonathan D Ashwell
Journal:  Curr Biol       Date:  2007-08-21       Impact factor: 10.834

8.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Authors:  Sandra Gardam; Frederic Sierro; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2008-02-28       Impact factor: 31.745

9.  Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation.

Authors:  Fengyi Wan; D Eric Anderson; Robert A Barnitz; Andrew Snow; Nicolas Bidere; Lixin Zheng; Vijay Hegde; Lloyd T Lam; Louis M Staudt; David Levens; Walter A Deutsch; Michael J Lenardo
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

Review 10.  Pellino proteins: novel players in TLR and IL-1R signalling.

Authors:  Reinout Schauvliege; Sophie Janssens; Rudi Beyaert
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more
  124 in total

Review 1.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 2.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

Review 3.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  Acute exercise activates myocardial nuclear factor kappa B.

Authors:  Marko Balan; Marius Locke
Journal:  Cell Stress Chaperones       Date:  2010-08-06       Impact factor: 3.667

Review 5.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 6.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

7.  Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules.

Authors:  Gloria Lopez-Castejón; Alberto Baroja-Mazo; Pablo Pelegrín
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

8.  Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.

Authors:  Shao-Cong Sun
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

9.  Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors.

Authors:  D De Silva; M D Mitchell; J A Keelan
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

10.  Nuclear factor-κB activation in primary lymphoma of bone.

Authors:  Lianne Koens; Fenna H Heyning; Agota Szepesi; András Matolcsy; Pancras C W Hogendoorn; Patty M Jansen
Journal:  Virchows Arch       Date:  2013-01-19       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.